PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 97 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $252,899 | -11.6% | 114,434 | +1.6% | 0.00% | – |
Q1 2023 | $286,162 | +38.3% | 112,662 | +1.8% | 0.00% | – |
Q4 2022 | $206,949 | -27.6% | 110,668 | -0.5% | 0.00% | – |
Q3 2022 | $286,000 | +37.5% | 111,243 | +3.3% | 0.00% | – |
Q2 2022 | $208,000 | -84.4% | 107,717 | -76.0% | 0.00% | – |
Q1 2022 | $1,335,000 | -36.3% | 449,337 | -3.7% | 0.00% | – |
Q4 2021 | $2,096,000 | -7.6% | 466,797 | -0.0% | 0.00% | – |
Q3 2021 | $2,269,000 | -30.8% | 466,871 | -2.9% | 0.00% | -100.0% |
Q2 2021 | $3,280,000 | -4.5% | 481,062 | -1.1% | 0.00% | 0.0% |
Q1 2021 | $3,433,000 | +2.9% | 486,290 | -8.8% | 0.00% | 0.0% |
Q4 2020 | $3,336,000 | +14.4% | 532,952 | -1.1% | 0.00% | 0.0% |
Q3 2020 | $2,915,000 | +0.0% | 538,937 | -3.5% | 0.00% | 0.0% |
Q2 2020 | $2,914,000 | +118.1% | 558,378 | +31.6% | 0.00% | – |
Q1 2020 | $1,336,000 | -16.9% | 424,142 | +6.4% | 0.00% | – |
Q4 2019 | $1,608,000 | -12.7% | 398,800 | -6.5% | 0.00% | – |
Q3 2019 | $1,842,000 | +11.4% | 426,389 | +2.9% | 0.00% | – |
Q2 2019 | $1,653,000 | -24.8% | 414,364 | +1.1% | 0.00% | -100.0% |
Q1 2019 | $2,197,000 | +3.7% | 409,847 | -0.7% | 0.00% | 0.0% |
Q4 2018 | $2,119,000 | -49.5% | 412,916 | -4.4% | 0.00% | 0.0% |
Q3 2018 | $4,192,000 | +0.5% | 432,090 | +5.7% | 0.00% | 0.0% |
Q2 2018 | $4,170,000 | -11.2% | 408,846 | +13.1% | 0.00% | 0.0% |
Q1 2018 | $4,698,000 | -17.9% | 361,406 | +13.0% | 0.00% | 0.0% |
Q4 2017 | $5,725,000 | -30.4% | 319,798 | -2.4% | 0.00% | -50.0% |
Q3 2017 | $8,223,000 | +3.5% | 327,617 | -0.6% | 0.00% | 0.0% |
Q2 2017 | $7,946,000 | +57.6% | 329,693 | +25.9% | 0.00% | +100.0% |
Q1 2017 | $5,041,000 | +33.4% | 261,899 | +6.7% | 0.00% | 0.0% |
Q4 2016 | $3,780,000 | +28.3% | 245,394 | +8.3% | 0.00% | 0.0% |
Q3 2016 | $2,947,000 | +22.5% | 226,581 | +31.0% | 0.00% | 0.0% |
Q2 2016 | $2,406,000 | +15.0% | 172,979 | +25.5% | 0.00% | 0.0% |
Q1 2016 | $2,092,000 | -18.1% | 137,871 | +2.4% | 0.00% | 0.0% |
Q4 2015 | $2,555,000 | +7.7% | 134,678 | +7.8% | 0.00% | 0.0% |
Q3 2015 | $2,373,000 | +388.3% | 124,922 | +563.6% | 0.00% | – |
Q2 2015 | $486,000 | – | 18,826 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,138,872 | $40,639,000 | 22.88% |
Abingworth LLP | 1,301,413 | $24,701,000 | 14.43% |
Roumell Asset Management, LLC | 201,845 | $3,835,000 | 7.78% |
GREAT POINT PARTNERS LLC | 453,878 | $8,624,000 | 3.41% |
Aisling Capital LLC | 682,680 | $12,971,000 | 2.28% |
Broadfin Capital, LLC | 530,283 | $10,075,000 | 0.56% |
Tekla Capital Management LLC | 762,581 | $14,489,000 | 0.52% |
Baupost Group | 1,544,498 | $29,345,000 | 0.49% |
GENERAL AMERICAN INVESTORS CO INC | 277,076 | $5,264,000 | 0.47% |
Lombard Odier Asset Management (USA) Corp | 135,710 | $2,578,000 | 0.22% |